Page last updated: 2024-08-21

quinazolines and Chronic Illness

quinazolines has been researched along with Chronic Illness in 80 studies

Research

Studies (80)

TimeframeStudies, this research(%)All Research%
pre-199044 (55.00)18.7374
1990's7 (8.75)18.2507
2000's22 (27.50)29.6817
2010's6 (7.50)24.3611
2020's1 (1.25)2.80

Authors

AuthorsStudies
Hong, S; Wiley, JW; Zheng, G; Zhu, S; Zong, Y1
Koskinen, PK; Palin, N; Rintala, JM; Rintala, SE; Savikko, J; von Willebrand, E1
Gong, GQ; Jiang, ML; Li, YZ; Wang, XH; Yan, W; Zhang, ZX1
Akay, OM; Andıç, N; Bolaman, AZ; Kadıköylü, VG; Ünübol, M; Yağcı, E; Yavaşoğlu, İ1
Tan, Q; Zhang, J1
Camidge, DR; Erickson, TM; Koeppe, JR; Miller, YE; Stuart, RW1
D'adda, M; Drera, M; Ferrari, S; Micheletti, M; Rossi, G1
Alexander, RB; Anderson, RU; Berger, R; Chuai, S; Krieger, JN; Kusek, JW; Landis, JR; Liong, ML; Litwin, MS; McNaughton-Collins, M; Nadler, R; Nickel, JC; Nyberg, LM; O'Leary, M; Pontari, M; Schaeffer, AJ; Shoskes, DA; White, PC; Zeitlin, S1
de Stricker, K; Hasselbalch, HC; Larsen, TS; Møller, MB; Pallisgaard, N1
Gisslinger, H; Krumpl, G; Linkesch, W; Petrides, PE; Schüller, A; Steurer, M; Widmann, R1
Wagenlehner, FM; Weidner, W1
Chadjichristos, C; Chatziantoniou, C; Dussaule, JC; Flamant, M; François, H; Guerrot, D; Helle, F; Jouzel, C; Placier, S1
Kattan, MW; Nickel, JC; Shoskes, DA1
Fu, H; Marelli-Berg, FM; McCormack, AM; Okkenhaug, K; Rose, ML; Sarathchandra, P; Ying, H1
Kvasnicka, HM; Schmitt-Gräff, A; Thiele, J1
Beaton, HG; Boughton-Smith, N; Cook, TR; Cooper, SL; Fraser-Rae, L; Hallam, K; Hamley, P; McInally, T; Nicholls, DJ; Pimm, AD; Tinker, AC; Wallace, AV1
Albitar, M; Colburn, DE; Cortes, JE; Giles, FJ; Kantarjian, HM; O'Brien, SM; Tsimberidou, AM; Verstovsek, S; Welch, MA1
Alas, P; Helström, PJ; Mehik, A; Nickel, JC; Sarpola, A1
Brunnbauer, K; Fuchs, N; Kvasnicka, HM; Schmitt-Graeff, A; Thiele, J; Volkwein, N1
Birgegård, G; Björkholm, M; Kutti, J; Lärfars, G; Löfvenberg, E; Markevärn, B; Mauritzson, N; Merup, M; Palmblad, J; Samuelsson, J; Westin, J1
Clausen, NT; Hansen, PB; Hasselbalch, HC; Jensen, BA; Mourits-Andersen, T; Nielsen, OJ; Penninga, E1
Bevan, S; Christiansen, M; Copp, P; Culshaw, AJ; Davis, A; Davis, C; Dyson, A; Dziadulewicz, EK; Edwards, L; Eggelte, H; Fox, A; Gentry, C; Groarke, A; Hallett, A; Hart, TW; Hughes, GA; Knights, S; Kotsonis, P; Lee, W; Lyothier, I; McBryde, A; McIntyre, P; Paloumbis, G; Panesar, M; Patel, S; Seiler, MP; Yaqoob, M; Zimmermann, K1
Jantunen, E; Kuittinen, T; Nousiainen, T; Penttilä, K1
Cabello, P; Cesar, JM; Ferro, T; Navarro, JL1
Lowe, FC; Santillo, VM1
Herzog, M; Hosemann, W; Kaftan, H; Lempas, K; Vogelgesang, S1
Cervantes, F1
Nickel, JC1
Fishman, AP; Janicki, JS; Kinasewitz, GT; Reichek, N; Weber, KT; West, JS1
Awan, NA; Lui, HK; Mason, DT1
Froer, KL; Hall, D; Rudolph, W1
Kaftańska, A; Paradowski, S; Szmydt, W1
Hagel, KJ; Netz, H; Rautenburg, HW; Röhner, G1
Guzińska, B; Nartowicz, E1
Koyanagi, T; Okamura, K; Takamatsu, T1
Coxon, R; Sharpe, DN1
Elenkova, A; Kaloianova, A; Nikolov, G; Terzieva, L; Tomov, I2
Bassand, JP; Becque, O; Bernard, Y; Berthout, P; Magnin, D; Maurat, JP; Vial, Y1
Rutishauser, W1
Clarke, GM; Cope, GD; Hockings, BE; Taylor, RR1
Forfang, K; Ihlen, H; Kjekshus, J; Thaulow, E1
Fukaya, T; Hayashi, H; Matsui, E; Niwa, T; Oba, M; Okubo, M; Sassa, H1
Henry, DP; Stein, L; Weinberger, MH1
Kukes, VG; Rumiantsev, AS; Shagako, EV; Shustikova, GB; Zisel'man, SB1
Bertel, O; Bühler, FR; Burkart, F1
Awan, NA; DeMaria, AN; Lee, G; Mason, DT1
Awan, NA; Mason, DT1
Boch, H; Kuhn, H; Lösse, B1
Silke, B; Taylor, SH1
Fukami, K; Fuseno, H; Haze, K; Hiramori, K; Honda, T; Ikeda, M; Saito, M; Tanaka, N; Umemoto, M1
Bussmann, WD1
Cabaniss, CD1
Bleifeld, W; Hanrath, P; Kuck, KH; Mathey, D; Zehnke, A1
Hołub, A; Robak, T; Treliński, J1
Fukuchi, Y; Hanasato, N; Kira, S; Nishino, M; Oka, M; Yamaguchi, K1
Sréter, L1
Anyukhovsky, EP; Danilo, P; Gainullin, RZ; Kirchengast, M; Rosen, MR; Sosunov, EA1
Feldman, EL; Greene, DA; Stevens, MJ1
Oka, M1
Ghimicescu, R1
Aronow, WS; Danahy, DT1
Elkayam, U; Frishman, WH; Lejemtel, TH; Mathur, M; Ribner, HS; Sonnenblick, EH; Strom, J1
Arnold, SB; Baughman, RA; Benet, LZ; Chatterjee, K; Parmley, WW; Ports, TA; Williams, RL1
Arnold, S; Brundage, B; Chatterjee, K; Parmley, W; Ports, TA1
Conti, CR; Iacona, M; Mehta, J; Pepine, CJ1
Awan, NA; Mason, DT; Miller, MP; Miller, RR; Specht, K; Vera, Z1
Gorlin, R; Herman, MV; Meller, J; Packer, M1
Braunwald, E1
Awan, NA; DeMaria, AN; Mason, DT; Maxwell, KS; Miller, RR; Neumann, A1
Hosoda, S; Kaneko, N; Kawagoe, Y; Kimata, S; Kimura, H; Konno, K; Miki, N; Nagashima, H; Sumiyoshi, T1
Ambrosioni, E; Borghi, C; Boschi, S; Costa, FV; Mussi, A1
Guba, GP; Tarasiuk, VK; Timko, NA1
Hasegawa, K; Inoue, S; Kawahara, Y; Nezuo, S; Sawayama, T; Tadaoka, S1
Fukuta, S; Itagaki, T; Kusukawa, R; Toma, Y; Umemoto, S; Yamakawa, K; Yoshinaga, T1
Champoud, O; Cribier, A; Letac, B1
Bussmann, WD; Kaltenbach, M; Nadj, M; Reifart, N; Schmidt-Moritz, AD1
Bayliss, J; Canepa-Anson, R; Norell, MS; Poole-Wilson, P; Reid, C; Sutton, G1
Ishii, M; Ito, I; Ogawa, T; Sekiguchi, T; Sugishita, Y1
Hillenbrand, P; Sherlock, S1

Reviews

6 review(s) available for quinazolines and Chronic Illness

ArticleYear
Evodiamine and Its Role in Chronic Diseases.
    Advances in experimental medicine and biology, 2016, Volume: 929

    Topics: Analgesics; Animals; Anti-Allergic Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Obesity Agents; Antineoplastic Agents, Phytogenic; Chronic Disease; Disease Models, Animal; Evodia; Humans; Molecular Structure; Phytotherapy; Plants, Medicinal; Quinazolines; Signal Transduction; Structure-Activity Relationship

2016
The management of chronic prostatitis in men with HIV.
    Current urology reports, 2006, Volume: 7, Issue:4

    Topics: Adrenergic alpha-Antagonists; Algorithms; Antiretroviral Therapy, Highly Active; Chronic Disease; Comorbidity; Cystoscopy; HIV Infections; Humans; Male; Pelvic Pain; Prostatitis; Quercetin; Quinazolines; Sulfonamides; Tamsulosin; Urodynamics

2006
Myelofibrosis: biology and treatment options.
    European journal of haematology. Supplementum, 2007, Issue:68

    Topics: Benzamides; Chronic Disease; Darbepoetin alfa; Erythropoietin; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Imatinib Mesylate; Interferon-alpha; Piperazines; Primary Myelofibrosis; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Recombinant Proteins; Splenectomy; Thalidomide

2007
Role of alpha1-blockers in chronic prostatitis syndromes.
    BJU international, 2008, Volume: 101 Suppl 3

    Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Ejaculation; Humans; Male; Pelvic Pain; Prostatism; Prostatitis; Quality of Life; Quinazolines; Randomized Controlled Trials as Topic; Secondary Prevention; Syndrome

2008
[Anagrelide--new antiplatelet drug].
    Acta haematologica Polonica, 1994, Volume: 25, Issue:4

    Topics: Animals; Chronic Disease; Humans; Megakaryocytes; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Quinazolines

1994
Diabetic neuropathy: scope of the syndrome.
    The American journal of medicine, 1999, Aug-30, Volume: 107, Issue:2B

    Topics: Aldehyde Reductase; Animals; Chronic Disease; Controlled Clinical Trials as Topic; Diabetic Foot; Diabetic Neuropathies; Disease Progression; Enzyme Inhibitors; Humans; Neural Conduction; Prevalence; Quinazolines; Syndrome

1999

Trials

16 trial(s) available for quinazolines and Chronic Illness

ArticleYear
Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome.
    The New England journal of medicine, 2008, Dec-18, Volume: 359, Issue:25

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Chronic Disease; Humans; Male; Middle Aged; Pelvic Pain; Prostatitis; Quinazolines; Severity of Illness Index; Treatment Failure; Young Adult

2008
Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation.
    Clinical therapeutics, 2009, Volume: 31, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Chromatography, High Pressure Liquid; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Humans; Longitudinal Studies; Male; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Randomized Controlled Trials as Topic; Solubility; Therapeutic Equivalency; Thrombocytosis; Young Adult

2009
Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Urology, 2003, Volume: 62, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Chronic Disease; Double-Blind Method; Humans; Male; Middle Aged; Pain Measurement; Pelvic Pain; Pilot Projects; Prospective Studies; Prostate-Specific Antigen; Prostatitis; Quinazolines; Treatment Outcome; Urodynamics

2003
Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.
    Haematologica, 2004, Volume: 89, Issue:5

    Topics: Adult; Aged; Chronic Disease; Diarrhea; Dose-Response Relationship, Drug; Female; Headache; Heart Rate; Humans; Male; Middle Aged; Myeloproliferative Disorders; Nausea; Patient Compliance; Patient Dropouts; Platelet Aggregation Inhibitors; Prospective Studies; Quinazolines; Thrombocytosis

2004
Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.
    Clinical and laboratory haematology, 2004, Volume: 26, Issue:5

    Topics: Adult; Aged; Anemia; Chronic Disease; Female; Hemorrhage; Humans; Male; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Quinazolines; Retrospective Studies; Thrombocytosis; Thromboembolism; Treatment Outcome

2004
[The use of anagrelide to treat thrombocytosis in connection with the chronic myeloproliferative disease].
    Duodecim; laaketieteellinen aikakauskirja, 2006, Volume: 122, Issue:4

    Topics: Administration, Oral; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Finland; Follow-Up Studies; Humans; Male; Myeloproliferative Disorders; Prospective Studies; Quinazolines; Risk Assessment; Thrombocytosis; Treatment Outcome

2006
Long-term vasodilator therapy with trimazosin in chronic cardiac failure.
    The New England journal of medicine, 1980, Jul-31, Volume: 303, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Carbon Dioxide; Chronic Disease; Clinical Trials as Topic; Echocardiography; Female; Heart Failure; Humans; Long-Term Care; Male; Middle Aged; Oxygen; Oxygen Consumption; Physical Exertion; Piperazines; Placebos; Pulmonary Ventilation; Quinazolines; Random Allocation; Vasodilator Agents

1980
[Clinical and polycardiographic evaluation of prazosin in the treatment of chronic congestive heart failure].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1984, Nov-12, Volume: 39, Issue:46

    Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Female; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Myocardial Contraction; Prazosin; Quinazolines

1984
Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
    Australian and New Zealand journal of medicine, 1982, Volume: 12, Issue:5

    Topics: Aged; Aldosterone; Blood Pressure; Captopril; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Proline; Pulmonary Wedge Pressure; Quinazolines; Random Allocation; Renin; Stroke Volume; Vascular Resistance

1982
[Treatment of chronic congestive failure with vasodilators (acute trial with prazosin and erythrityl tetranitrate)].
    Vutreshni bolesti, 1982, Volume: 21, Issue:6

    Topics: Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Clinical Trials as Topic; Erythrityl Tetranitrate; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Prazosin; Quinazolines; Stroke Volume; Vascular Resistance

1982
Prazosin in the treatment of severe chronic congestive cardiac failure.
    Australian and New Zealand journal of medicine, 1980, Volume: 10, Issue:4

    Topics: Adult; Aged; Chronic Disease; Echocardiography; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines

1980
Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.
    The American journal of medicine, 1981, Volume: 70, Issue:4

    Topics: Aged; Chronic Disease; Clinical Trials as Topic; Drug Tolerance; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroprusside; Norepinephrine; Prazosin; Quinazolines; Renin

1981
[Vasodilator treatment of chronic heart failure: a chronic double-blind trial with prazosin and erythrityl tetranitrate].
    Vutreshni bolesti, 1981, Volume: 20, Issue:6

    Topics: Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Erythrityl Tetranitrate; Female; Heart Failure; Hemodynamics; Humans; Male; Placebos; Prazosin; Quinazolines

1981
Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure.
    The American journal of medicine, 1978, Volume: 65, Issue:1

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Heart; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Physical Exertion; Piperazines; Placebos; Prazosin; Quinazolines; Vasodilator Agents

1978
[Lack of symptomatic and long-term hemodynamic effects of prazosin in chronic heart failure. Double-blind, randomized study over one year].
    Zeitschrift fur Kardiologie, 1985, Volume: 74, Issue:4

    Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Heart Valve Prosthesis; Hemodynamics; Humans; Long-Term Care; Middle Aged; Postoperative Complications; Prazosin; Quinazolines

1985
Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.
    British medical journal (Clinical research ed.), 1985, Jun-22, Volume: 290, Issue:6485

    Topics: Aged; Captopril; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prazosin; Proline; Quinazolines; Renin-Angiotensin System; Time Factors

1985

Other Studies

58 other study(ies) available for quinazolines and Chronic Illness

ArticleYear
Histone H3K9 methylation regulates chronic stress and IL-6-induced colon epithelial permeability and visceral pain.
    Neurogastroenterology and motility, 2020, Volume: 32, Issue:12

    Topics: Animals; Caco-2 Cells; Chronic Disease; Colon; Epithelium; Histones; Humans; Interleukin-6; Male; Methylation; Permeability; Quinazolines; Rats; Rats, Sprague-Dawley; Stress, Psychological; Visceral Pain

2020
Epidermal growth factor inhibition, a novel pathway to prevent chronic allograft injury.
    Transplantation, 2014, Oct-27, Volume: 98, Issue:8

    Topics: Animals; Aorta; Chronic Disease; Epidermal Growth Factor; Erlotinib Hydrochloride; Graft Rejection; Immunohistochemistry; Kidney; Kidney Transplantation; Male; Quinazolines; Rats; Rats, Wistar; Transplantation, Homologous

2014
Antidepressant-like effect of evodiamine on chronic unpredictable mild stress rats.
    Neuroscience letters, 2015, Feb-19, Volume: 588

    Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Chronic Disease; Corticosterone; Hippocampus; Male; Norepinephrine; Phosphorylation; Quinazolines; Rats, Sprague-Dawley; Receptor, trkB; RNA, Messenger; Serotonin; Stress, Psychological

2015
Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms.
    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2016, Sep-05, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Hemorrhage; Humans; Hydroxyurea; Janus Kinase 2; Male; Middle Aged; Mutation; Myeloproliferative Disorders; Quinazolines; Retrospective Studies; Risk Factors; Turkey; Venous Thromboembolism; Young Adult

2016
Bronchioloalveolar carcinoma presenting as chronic progressive pulmonary infiltrates in a woman with HIV: a diagnosis worth making.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2008, Volume: 3, Issue:11

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Chronic Disease; Diagnosis, Differential; ErbB Receptors; Erlotinib Hydrochloride; Female; HIV; HIV Infections; Humans; Lung Diseases, Interstitial; Middle Aged; Mutation; Prognosis; Protein Kinase Inhibitors; Quinazolines

2008
The combined use of hydroxyurea and anagrelide allows satisfactory hematologic control in patients with chronic myeloproliferative disorders and thrombocytosis: a report on 13 patients with poor tolerance to hydroxyurea monotherapy.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:11

    Topics: Adult; Aged; Blood Platelets; Chronic Disease; Drug Therapy, Combination; Drug Tolerance; Female; Hemoglobins; Humans; Hydroxyurea; Male; Middle Aged; Myeloproliferative Disorders; Quinazolines; Retrospective Studies; Thrombocytosis

2008
Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden.
    Hematology (Amsterdam, Netherlands), 2009, Volume: 14, Issue:1

    Topics: Alleles; Chronic Disease; Female; Humans; Hydroxyurea; Janus Kinase 2; Male; Mutation; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Polymerase Chain Reaction; Prospective Studies; Quinazolines

2009
Prostatitis: no benefit of alpha-blockers for chronic prostatitis.
    Nature reviews. Urology, 2009, Volume: 6, Issue:4

    Topics: Adrenergic alpha-Antagonists; Chronic Disease; Humans; Male; Prostatitis; Quinazolines; Randomized Controlled Trials as Topic

2009
Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.
    American journal of physiology. Renal physiology, 2009, Volume: 297, Issue:1

    Topics: Animals; Arterioles; Blood Pressure; Chronic Disease; Disease Models, Animal; Enzyme Inhibitors; ErbB Receptors; Gefitinib; Hypertension; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Quinazolines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasoconstriction

2009
Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
    Urology, 2010, Volume: 75, Issue:6

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Benzhydryl Compounds; Chronic Disease; Cohort Studies; Cresols; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Pain Measurement; Pelvic Pain; Phenotype; Phenylpropanolamine; Probability; Prospective Studies; Prostatitis; Quinazolines; Risk Assessment; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Young Adult

2010
Genetic or pharmaceutical blockade of phosphoinositide 3-kinase p110δ prevents chronic rejection of heart allografts.
    PloS one, 2012, Volume: 7, Issue:3

    Topics: Adenine; Animals; Cells, Cultured; Chronic Disease; Class Ia Phosphatidylinositol 3-Kinase; Female; Flow Cytometry; Graft Rejection; H-Y Antigen; Heart Transplantation; Humans; Immune Tolerance; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Fluorescence; Phosphoinositide-3 Kinase Inhibitors; Quinazolines; Skin Transplantation; T-Lymphocytes; Transplantation, Homologous

2012
[Anagrelide-induced changes of megakaryopoiesis during therapy of chronic myeloproliferative disorders with thrombocythemia].
    Der Pathologe, 2002, Volume: 23, Issue:6

    Topics: Blood Platelets; Chronic Disease; Fibrinolytic Agents; Humans; Megakaryocytes; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Platelet Count; Proliferating Cell Nuclear Antigen; Quinazolines; Reference Values; Retrospective Studies; Thrombocytosis; Thrombopoiesis

2002
1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.
    Journal of medicinal chemistry, 2003, Mar-13, Volume: 46, Issue:6

    Topics: Acute Disease; Administration, Oral; Amines; Animals; Arthritis, Experimental; Cell Line; Chronic Disease; Enzyme Inhibitors; Injections, Intravenous; Isoenzymes; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Quinazolines; Rats; Spiro Compounds; Structure-Activity Relationship

2003
Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders.
    Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Benzamides; Chronic Disease; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fibrinolytic Agents; Humans; Imatinib Mesylate; Male; Medical Records Systems, Computerized; Middle Aged; Myeloproliferative Disorders; Piperazines; Pyrimidines; Quinazolines; Retrospective Studies; Survival Analysis

2003
Anagrelide-induced bone marrow changes during therapy of chronic myeloproliferative disorders with thrombocytosis. an immunohistochemical and morphometric study of sequential trephine biopsies.
    Haematologica, 2003, Volume: 88, Issue:10

    Topics: Adult; Aged; Biopsy; Blood Platelets; Bone Marrow; Chronic Disease; Drug Evaluation; Humans; Immunohistochemistry; Middle Aged; Myeloproliferative Disorders; Platelet Count; Quinazolines; Retrospective Studies; Thrombocytosis

2003
Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain.
    Journal of medicinal chemistry, 2006, Jan-26, Volume: 49, Issue:2

    Topics: Animals; Blood-Brain Barrier; Caco-2 Cells; Cell Membrane Permeability; CHO Cells; Chronic Disease; Cricetinae; Cricetulus; Disease Models, Animal; Humans; In Vitro Techniques; Mice; Micronucleus Tests; Microsomes, Liver; Pain; Quinazolines; Rats; Solubility; Structure-Activity Relationship; TRPV Cation Channels

2006
Emergence of chronic myelogenous leukemia in a patient with primary thrombocythemia and absence of BCR/ABL rearrangement.
    Cancer genetics and cytogenetics, 2006, Volume: 167, Issue:1

    Topics: Aged; Antineoplastic Agents; Benzamides; Blood Platelets; Bone Marrow Cells; Cells, Cultured; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Chronic Disease; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Fusion Proteins, bcr-abl; Humans; Hydroxyurea; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytes; Piperazines; Pyrimidines; Quinazolines; Thrombocythemia, Essential; Time Factors; Translocation, Genetic; Treatment Outcome

2006
Inhibition of epidermal growth factor receptor by erlotinib: wound healing of experimental tympanic membrane perforations.
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2007, Volume: 28, Issue:2

    Topics: Animals; Chronic Disease; ErbB Receptors; Erlotinib Hydrochloride; Protein Kinase Inhibitors; Quinazolines; Rats; Tympanic Membrane Perforation; Wound Healing

2007
Effects of alpha-receptor blockade with prazosin in advanced chronic congestive heart failure.
    Herz, 1983, Volume: 8, Issue:2

    Topics: Chronic Disease; Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines; Receptors, Adrenergic, alpha; Water-Electrolyte Balance

1983
[Captopril in chronic congestive heart failure--dose-effect behavior and comparison with prazosin].
    Herz, 1983, Volume: 8, Issue:2

    Topics: Adult; Aged; Captopril; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Proline; Quinazolines

1983
Prazosin for refractory cardiac failure in children.
    Pediatric cardiology, 1984, Volume: 5, Issue:4

    Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Heart Failure; Humans; Infant; Male; Prazosin; Quinazolines

1984
[Effect of vasodilator treatment of chronic circulatory insufficiency on various polycardiographic parameters].
    Kardiologia polska, 1983, Volume: 26, Issue:7

    Topics: Chronic Disease; Drug Therapy, Combination; Female; Heart; Heart Failure; Heart Function Tests; Humans; Male; Prazosin; Quinazolines; Vasodilator Agents

1983
[Management of chronic spinal cord injury patients with prazosin].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1983, Volume: 74, Issue:9

    Topics: Adult; Chronic Disease; Female; Humans; Male; Middle Aged; Prazosin; Quinazolines; Spinal Cord Injuries; Urination Disorders; Urodynamics

1983
[Hemodynamic effects of prazosin in chronic congestive heart failure].
    Archives des maladies du coeur et des vaisseaux, 1980, Volume: 73, Issue:6

    Topics: Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines

1980
A review of the long-term effects of prazosin and hydralazine in chronic congestive heart failure.
    European heart journal, 1983, Volume: 4 Suppl A

    Topics: Chronic Disease; Drug Therapy, Combination; Follow-Up Studies; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Quinazolines; Spironolactone; Time Factors

1983
Loss of prazosin effect in severe chronic CHF.
    Acta medica Scandinavica. Supplementum, 1981, Volume: 652

    Topics: Adult; Aged; Bed Rest; Chronic Disease; Drug Tolerance; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines

1981
Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Japanese heart journal, 1980, Volume: 21, Issue:6

    Topics: Administration, Oral; Aged; Blood Pressure; Chronic Disease; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Renin; Vascular Resistance

1980
[Use of the new hypotensive agent Minipress (prazosin hydrochloride].
    Kardiologiia, 1982, Volume: 22, Issue:3

    Topics: Adult; Antihypertensive Agents; Chronic Disease; Drug Evaluation; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Prazosin; Quinazolines; Time Factors

1982
Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
    American heart journal, 1981, Volume: 101, Issue:5

    Topics: Aged; Chronic Disease; Dizziness; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Pulmonary Wedge Pressure; Quinazolines; Stroke Volume; Vascular Resistance; Vasodilator Agents

1981
Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
    American heart journal, 1981, Volume: 101, Issue:5

    Topics: Administration, Oral; Ambulatory Care; Chronic Disease; Drug Tolerance; Forearm; Heart Failure; Hemodynamics; Humans; Plethysmography, Impedance; Prazosin; Quinazolines; Regional Blood Flow; Vascular Resistance

1981
Oral vasodilator therapy with prazosin in severe congestive heart failure.
    American heart journal, 1981, Volume: 101, Issue:5

    Topics: Acute Disease; Administration, Oral; Ambulatory Care; Chronic Disease; Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines; Vascular Resistance; Vasodilator Agents

1981
[Chronic administration of prazosin in patients with congestive cardiomyopathy (author's transl)].
    Zeitschrift fur Kardiologie, 1981, Volume: 70, Issue:7

    Topics: Adult; Chronic Disease; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines

1981
Pharmacokinetic and haemodynamic studies with prazosin in chronic heart failure.
    Irish journal of medical science, 1981, Volume: 150, Issue:8

    Topics: Aged; Blood Pressure; Chronic Disease; Coronary Disease; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Posture; Prazosin; Pulmonary Artery; Quinazolines

1981
[The effects of prazosin in patients with chronic refractory heart failure-acute hemodynamic effects of oral prazosin and long-term therapy (author's transl)].
    Kokyu to junkan. Respiration & circulation, 1981, Volume: 29, Issue:5

    Topics: Administration, Oral; Adult; Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines

1981
[Acute and chronic treatment of chronic cardiac insufficiency with nitrates or prazosin respectively].
    Therapeutische Umschau. Revue therapeutique, 1981, Volume: 38 Suppl

    Topics: Acute Disease; Chronic Disease; Heart Failure; Humans; Nitrates; Prazosin; Quinazolines

1981
Vasodilator therapy of chronic congestive heart failure.
    Journal of the Medical Association of Georgia, 1980, Volume: 69, Issue:2

    Topics: Ambulatory Care; Chronic Disease; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Quinazolines

1980
[Prazosin long-term treatment in severe chronic cardiac failure (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1980, Oct-03, Volume: 105, Issue:40

    Topics: Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Digitalis Glycosides; Diuretics; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Prazosin; Pulmonary Artery; Quinazolines

1980
[E 4021, a cGMP phosphodiesterase inhibitor, is a selective pulmonary vasodilator in chronically hypoxic pulmonary hypertensive rats].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 1998, Volume: 36, Issue:1

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Pressure; Chronic Disease; Hypertension, Pulmonary; Hypoxia; Lung; Male; Phosphodiesterase Inhibitors; Piperidines; Pulmonary Artery; Quinazolines; Rats; Rats, Sprague-Dawley; Vasodilator Agents

1998
[Chronic myeloproliferative diseases].
    Orvosi hetilap, 1998, Jul-26, Volume: 139, Issue:30

    Topics: Chronic Disease; Female; Fibrinolytic Agents; Humans; Interferons; Leukemia, Myeloid; Male; Myeloproliferative Disorders; Polycythemia Vera; Primary Myelofibrosis; Quinazolines; Thrombocythemia, Essential

1998
Electrophysiological effects of LU111995 on canine hearts: in vivo and in vitro studies.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:1

    Topics: Action Potentials; Animals; Antipsychotic Agents; Chronic Disease; Dogs; Electrocardiography; Electrophysiology; Female; Fumarates; Heart; Heart Block; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Purkinje Fibers; Quinazolines; Refractory Period, Electrophysiological

1999
Phosphodiesterase 5 inhibition restores impaired ACh relaxation in hypertensive conduit pulmonary arteries.
    American journal of physiology. Lung cellular and molecular physiology, 2001, Volume: 280, Issue:3

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Acetylcholine; Animals; Chronic Disease; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Hypertension; Hypoxia; In Vitro Techniques; Male; Nitroprusside; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Pulmonary Artery; Quinazolines; Rats; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents

2001
[Effect and tolerance of Biarison (proquazone) in rheumatoid arthritis (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1978, Jun-30, Volume: 120, Issue:26

    Topics: Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Chronic Disease; Humans; Middle Aged; Quinazolines

1978
Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
    The American journal of cardiology, 1979, Volume: 44, Issue:3

    Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Time Factors; Vascular Resistance

1979
Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Annals of internal medicine, 1979, Volume: 91, Issue:3

    Topics: Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Stroke Volume; Vascular Resistance

1979
Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
    British heart journal, 1979, Volume: 42, Issue:6

    Topics: Adult; Aged; Cardiac Output; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Prazosin; Quinazolines; Vascular Resistance

1979
Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
    British heart journal, 1979, Volume: 42, Issue:6

    Topics: Adult; Aged; Chronic Disease; Ferricyanides; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Nitroprusside; Prazosin; Quinazolines

1979
Clinical pharmacology and therapeutic application of prazosin in acute and chronic refractory congestive heart failure. Balanced systemic venous and arterial dilation improving pulmonary congestion and cardiac output.
    The American journal of medicine, 1978, Volume: 65, Issue:1

    Topics: Acute Disease; Arteries; Cardiac Output; Chronic Disease; Electrocardiography; Forearm; Heart Failure; Heart Ventricles; Humans; Physical Exertion; Plethysmography; Prazosin; Pulmonary Edema; Quinazolines; Vasodilation; Veins

1978
Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.
    Circulation, 1979, Volume: 59, Issue:3

    Topics: Aged; Chronic Disease; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Middle Aged; Prazosin; Quinazolines; Tachyphylaxis; Time Factors

1979
Vasodilator therapy--a physiologic approach to the treatment of heart failure.
    The New England journal of medicine, 1977, Aug-11, Volume: 297, Issue:6

    Topics: Administration, Oral; Advertising; Chronic Disease; Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines; Vasodilator Agents

1977
Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodyn
    Circulation, 1977, Volume: 56, Issue:3

    Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Blood Pressure; Cardiac Output; Chronic Disease; Coronary Disease; Drug Evaluation; Dyspnea; Echocardiography; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Vascular Resistance; Vasodilator Agents

1977
[The acute and chronic effects of bunazosin on exercise capacity estimated by the anaerobic threshold in patients with chronic congestive heart failure].
    Kokyu to junkan. Respiration & circulation, 1992, Volume: 40, Issue:11

    Topics: Adult; Aged; Anaerobic Threshold; Chronic Disease; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Quinazolines

1992
Hemodynamic and humoral effects of chronic antihypertensive treatment with fenquizone: importance of aldosterone response.
    Journal of clinical pharmacology, 1990, Volume: 30, Issue:3

    Topics: Adult; Aldosterone; Blood Pressure; Chronic Disease; Diuretics; Female; Forearm; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Quinazolines; Regional Blood Flow; Renin; Sulfonamides; Vascular Resistance

1990
[The use of deoxypeganin hydrochloride in the combined treatment of patients with diseases of the peripheral nervous system].
    Vrachebnoe delo, 1989, Issue:3

    Topics: Adult; Alkaloids; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Muscle Tonus; Peripheral Nervous System Diseases; Quinazolines

1989
[Acute and chronic effects of bunazosin in patients with congestive heart failure].
    Kokyu to junkan. Respiration & circulation, 1989, Volume: 37, Issue:5

    Topics: Adrenergic alpha-Antagonists; Atrial Natriuretic Factor; Chronic Disease; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinazolines

1989
Hemodynamic benefits of long-term bunazosin (alpha-1 blocker) therapy in rats with myocardial infarction and heart failure.
    Japanese circulation journal, 1989, Volume: 53, Issue:4

    Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cardiac Output, Low; Chronic Disease; Female; Heart Ventricles; Hemodynamics; Myocardial Infarction; Quinazolines; Rats; Rats, Inbred Strains; Vascular Resistance; Weight Gain

1989
[Prazosin in the treatment of chronic cardiac insufficiency].
    Annales de medecine interne, 1985, Volume: 136, Issue:3

    Topics: Adrenergic alpha-Antagonists; Arterioles; Cardiac Output; Chronic Disease; Heart Failure; Humans; Middle Aged; Prazosin; Pulmonary Wedge Pressure; Quinazolines; Time Factors; Veins

1985
[Correlations between resting hemodynamics and exercise tolerance before and after prazosin therapy in patients with chronic congestive heart failure].
    Kokyu to junkan. Respiration & circulation, 1985, Volume: 33, Issue:2

    Topics: Adult; Aged; Chronic Disease; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Rest

1985
Use of metolazone in the treatment of ascites due to liver disease.
    British medical journal, 1971, Oct-30, Volume: 4, Issue:5782

    Topics: Adult; Ascites; Chlorides; Chronic Disease; Diuretics; Female; Hepatic Encephalopathy; Humans; Hypokalemia; Hyponatremia; Ketones; Liver Diseases; Male; Middle Aged; Nitrogen; Pyrazines; Quinazolines; Spironolactone; Sulfonamides; Uremia

1971